Stamford, CT -- (SBWIRE) -- 01/25/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Penn Virginia Corporation (NYSE:PVA), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Integrated Device Technology Inc (NASDAQ:IDTI), Thompson Creek Metals Company Inc (USA) (NYSE:TC)
Penn Virginia Corporation (NYSE:PVA) opened the session at $11.78, trading in a range of $11.62 - $12.25. The stock showed a positive performance of +1.18% in the last trading session from its previous close of $11.88 and closed at $12.02. The stock traded on a volume of 2.62 million shares and the average volume of the stock remained 2.85 million shares. Penn Virginia Corporation (Penn Virginia) is an independent oil and gas company engaged primarily in the exploration, development and production of oil, natural gas liquids (NGL) and natural gas in various domestic onshore regions of the United States, including Texas, the Mid-Continent and Mississippi. As of December 31, 2012, the Company's proved reserves were approximately 113 million barrels of oil per day , of which 41% were proved developed reserves and 40% were oil and NGLs.
For How Long PVA will Fight for Profitability? Read This Trend Analysis report
Halozyme Therapeutics, Inc. (NASDAQ:HALO) traded 2.60 million shares in the last business day while the average volume of the stock remained 1.58 million shares. The stock showed a negative movement of -5.81% to end at $16.55. The 52 week range of the stock remained $5.03 - $18.18. Halozyme Therapeutics, Inc. is a biopharmaceutical company. The Company’s research focuses primarily on human enzymes that alter the extracellular matrix. The Company’s pipeline consists of multiple clinical stage products in diabetes, oncology and dermatology. The product candidates in its pipeline are based on rHuPH20, a patented human recombinant hyaluronidase enzyme. rHuPH20 temporarily breaks down hyaluronic acid (HA), a naturally occurring substance that is a component of the extracellular matrix in tissues throughout the body, such as skin and cartilage.
Has HALO Found The Bottom And Ready To Gain Momentum? Find Out Here
Integrated Device Technology Inc (NASDAQ:IDTI) reported 2.55 million shares were exchanged during the last trade, while the average volume is about 1.89 million shares. The stock dropped -3.23% and finished the day at $10.47. The beta of the stock is recorded at 1.66. Integrated Device Technology, Inc. (IDT) designs, develops, manufactures and markets a broad range of low-power mixed signal semiconductor solutions for the advanced communications, computing and consumer industries. The Company operates in the Communications segment and the Computing and Consumer segment.
Why Should Investors Buy IDTI After the Recent Fall? Just Go Here and Find Out
Thompson Creek Metals Company Inc (USA) (NYSE:TC) shares dropped -6.30 percent from its previous close of $2.70 to close at $2.53. Traded with volume of 2.55 million shares in the prior session and the average volume of the stock remained 2.19 million shares. Thompson Creek Metals Company Inc. is a diversified mining company. It is a producer of molybdenum and has copper and gold reserves. It operates in three segments: US Operations Molybdenum, Canadian Operations Molybdenum, and Copper-Gold (Development).
Will TC Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)